National Cancer Institute (NCI): Papillomavirus Infections trials

The registry lists 20 Papillomavirus Infections studies with National Cancer Institute (NCI) as lead sponsor. 3 are open to participants now and 7 have results posted.

Phase 1 1Phase 2 11Phase 4 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)Not yet recruitingNCT07756840Phase 2
• ESCUDDO Long Term Follow UpEnrolling by invitationNCT07706673Phase 4
• Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)RecruitingNCT07281430Not applicable
• E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal CancerTerminatedNCT04015336Phase 2Results posted
• M7824 in People With Recurrent Respiratory PapillomatosisCompletedNCT03707587Phase 2Results posted
• Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant RecipientsActive, not recruitingNCT03036930Phase 2Results posted
• Avelumab for People With Recurrent Respiratory PapillomatosisCompletedNCT02859454Phase 2Results posted
• E7 TCR T Cells for Human Papillomavirus-Associated CancersCompletedNCT02858310Phase 1/2Results posted
• Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical CancerCompletedNCT01693783Phase 2Results posted
• Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial NeoplasiaCompletedNCT00303823Phase 2Results posted
• Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)Active, not recruitingNCT06611553Not applicable
• Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)Active, not recruitingNCT06611540Not applicable
• Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)Active, not recruitingNCT06498661Not applicable
• Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)Active, not recruitingNCT05797246Phase 2
• A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal CancerWithdrawnNCT04044950Phase 2
• Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT StudyActive, not recruitingNCT03309033
• Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO StudyActive, not recruitingNCT03180034Phase 4
• Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191CompletedNCT01086709
• Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated ControlsActive, not recruitingNCT00867464
• Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial NeoplasiaCompletedNCT00054041Phase 2